Beautifully designed, easy to use, and incredibly useful, SECRET is the “iPhone” of QA databases. At hospital Level, it could Be a tremendous help in identifying where our process works smoothly, and where we should target to improve further. With the click of a button, we can get a summary of results for any performance measure relative to demographics, outcomes, required performance metrics, and more. The individual patient timelines clearly show where delays occurred; This feature which could be used at QA meetings might improve how we care for patients. SECRET could be useful to our ED, stroke coordinators, physicians, and hospital administrators – the entire stroke team.
Cost effectiveness of the treatment
Stroke is an expensive disease from a patient, caregiver, and societal perspective. In spite of the high cost burden, only limited numbers of recent studies have focused on stroke-related costs.
The lifetime cost per person of first strokes occurring in 1990 is estimated ,in literature, to be $228 030 for SAH, $123 565 for ICH, $90 981 for ISC.
The Aggregate lifetime cost associated with an estimated 392 344 first strokes in 1990 was $40.6 billion: $5.6 billion for SAH, $6.0 billion for ICH, and $29.0 billion for ISC.
Acute-care costs incurred in the 2 years following a first stroke accounted for 45.0%, long-term ambulatory care accounted for 35.0%, and nursing home costs accounted for 17.5% of aggregate lifetime costs of stroke.
SECRET is the first of its type registry to study the parameters for cost/effectiveness for specific steps in the chain of treatment and care for stroke patient. The only convincing tool which could be used to approach the politics to be attentive and malleable for national plans for care. We are convinced that the gap in medical care services from point between what should to be and what is real is due to miscommunication between both medical community and political decision makers in the region specially in the developing area of the world where money talks.